Literature DB >> 21270147

Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin).

Steve M Fernandes1, Edward J Brignole, Kanchan Taori, Wade Gibson.   

Abstract

We compared the full-length capsid maturational protease (pPR, pUL80a) of human cytomegalovirus with its proteolytic domain (assemblin) for the ability to cleave two biological substrates, and we found that pPR is more efficient with both. Affinity-purified, refolded enzymes and substrates were combined under defined reaction conditions, and cleavage was monitored and quantified following staining of the resulting electrophoretically separated fragments. The enzymes were stabilized against self-cleavage by a single point mutation in each cleavage site (ICRMT-pPR and IC-assemblin). The substrates were pPR itself, inactivated by replacing its catalytic nucleophile (S132A-pPR), and the sequence-related assembly protein precursor (pAP, pUL80.5). Our results showed that (i) ICRMT-pPR is 5- to 10-fold more efficient than assemblin for all cleavages measured (i.e., the M site of pAP and the M, R, and I sites of S132A-pPR). (ii) Cleavage of substrate S132A-pPR proceeded M>R>I for both enzymes. (iii) Na(2)SO(4) reduced M- and R-site cleavage efficiency by ICRMT-pPR, in contrast to its enhancing effect for both enzymes on I site and small peptide cleavage. (iv) Disrupting oligomerization of either the pPR enzyme or substrate by mutating Leu382 in the amino-conserved domain reduced cleavage efficiency two- to fourfold. (v) Finally, ICRMT-pPR mutants that include the amino-conserved domain, but terminate with Pro481 or Tyr469, retain the enzymatic characteristics that distinguish pPR from assemblin. These findings show that the scaffolding portion of pPR increases its enzymatic activity on biologically relevant protein substrates and provide an additional link between the structure of this essential viral enzyme and its biological mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270147      PMCID: PMC3067851          DOI: 10.1128/JVI.02663-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Recombinant full-length human cytomegalovirus protease has lower activity than recombinant processed protease domain in purified enzyme and cell-based assays.

Authors:  Arthur J Wittwer; Christy L Funckes-Shippy; Paul J Hippenmeyer
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

2.  The amino-conserved domain of human cytomegalovirus UL80a proteins is required for key interactions during early stages of capsid formation and virus production.

Authors:  Amy N Loveland; Nang L Nguyen; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.

Authors:  V G Preston; J A Coates; F J Rixon
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

5.  Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease.

Authors:  R Batra; R Khayat; L Tong
Journal:  Nat Struct Biol       Date:  2001-09

6.  The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus.

Authors:  Marlyse Buisson; Jean-François Hernandez; David Lascoux; Guy Schoehn; Eric Forest; Gérard Arlaud; Jean-Marie Seigneurin; Rob W H Ruigrok; Wim P Burmeister
Journal:  J Mol Biol       Date:  2002-11-15       Impact factor: 5.469

7.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.

Authors:  Alan B Marnett; Anson M Nomura; Nobuhisa Shimba; Paul R Ortiz de Montellano; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

9.  Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.

Authors:  Nang L Nguyen; Amy N Loveland; Wade Gibson
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.

Authors:  Phong Trang; Kihoon Kim; Jiaming Zhu; Fenyong Liu
Journal:  J Mol Biol       Date:  2003-05-16       Impact factor: 5.469

View more
  1 in total

1.  Computational modeling of protracted HCMV replication using genome substrates and protein temporal profiles.

Authors:  Christopher E Monti; Rebekah L Mokry; Megan L Schumacher; Ranjan K Dash; Scott S Terhune
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.